Arkhangel'skiy Klinicheskiy Onkologicheskiy Dispanser

Recent papers from Arkhangel'skiy Klinicheskiy Onkologicheskiy Dispanser

1. Understanding as Holding a Concept Together and the Testing of Language Models (Towards a Research Methodology)2026
2. Prevalence and Species Diversity of Spotted Fever Group Rickettsiae in Ixodid Ticks Collected in Northwest RussiaTropical Medicine and Infectious Disease · 2026
3. Primary treatment approaches in advanced HRD-positive (BRCAm and BRCAwt) ovarian cancer in the Russian non-interventional OVARD study.Journal of Clinical Oncology · 2026
4. Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma and venous tumor thrombus: Results from the first analysis of the PELET trial.Journal of Clinical Oncology · 2026
5. Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participantsFrontiers in Molecular Biosciences · 2026
6. Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: results from the randomised, global phase III CAPItello-290 trialAnnals of Oncology · 2025
7. Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate CarcinomasInternational Journal of Molecular Sciences · 2025
8. Preventive Treatment of Tuberculosis with Fluoroquinolones Including Moxifloxacin in Children Exposed to Multidrug-Resistant TuberculosisTuberculosis and lung diseases · 2025
9. 600- vs 400-mg First-Line Ribociclib in Hormone Receptor–Positive/ERBB2-Negative Advanced Breast CancerJAMA Oncology · 2025
10. Attitudes and ethical beliefs of Russian psychiatrists towards the use of coercive treatment practicesInternational Journal of Law and Psychiatry · 2025
11. Real-world outcomes of lenvatinib plus pembrolizumab in intermediateand poor-risk metastatic renal cell carcinomaCancer Urology · 2025
12. Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian PatientsCancers · 2025
13. Conditional survival of children, adolescents and young adults (0–24 years) diagnosed with leukaemia during 2000–2014 world-wide: (CONCORD-3)European Journal of Cancer · 2025
14. Assessment of the effectiveness of continuous erector spinae plane block versus continuous thoracic epidural analgesia following major thoracic surgeryRegional Anesthesia and Acute Pain Management · 2025
15. Monitoring of Mutations Associated with Drug Resistance of Mycobacterium tuberculosisTuberculosis and lung diseases · 2025
16. Follow up of clinical outcomes in type 1 diabetic patients according to the results of dynamic examination in the mobile center "Diamobil"Consilium Medicum · 2024
17. Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocolЭкология человека · 2024
18. Study of the state of humoral immunity to COVID-19 in Arkhangelsk residentsRussian Journal of Immunology · 2024
19. Use of empegfilgrastim for primary prevention of febrile neutropenia in patients receiving myelosuppressive therapy. Experience of the Arkhangelsk Clinical Oncological DispensaryPodderživaûŝaâ terapiâ v onkologii. · 2024
20. Effectiveness and safety of empegfilgrastim (Extimia®) in patients with solid tumors receiving cytotoxic therapy: final results of the DEFENDOR studyJournal of Modern Oncology · 2024